SHP INHIBITOR COMPOSITIONS AND USES FOR CHIMERIC ANTIGEN RECEPTOR THERAPY

METHODS AND COMPOSITIONS FOR INDUCING NEURAL PLASTICITY

HIGH AFFINITY SIRP-ALPHA REAGENTS AND METHODS OF USING

PTPRS IN AUTOIMMUNITY

SIRP-ALPHA VARIANT CONSTRUCTS AND USES THEREOF

CELL PENETRATING PEPTIDES AND METHODS OF MAKING AND USING THEREOF

Fusion Proteins for Dephosphorylating Proteins that Regulate T Cell Activation through the TCR Signaling Pathway

CRISPR-Cas9 Knock-out of SHP-1/2 to Reduce T cell Exhaustion in Adoptive Cell Therapy

Antigen-Presenting Polypeptides with Chemical Conjugation Sites and Methods of Use Thereof

SYNTHETIC INTERMEMBRANE PROTEOLYSIS RECEPTORS FOR CUSTOM ANTIGEN-INDUCED TRANSCRIPTIONAL REGULATION

GENETICALLY MODIFIED NON-HUMAN ANIMALS EXPRESSING HUMAN EPO

Cell

CELL

Oncolytic viruses targeting STAT3

MODIFIED IPSCS

Methods and Materials for Producing Polyols and Electron Rich Compounds

PTPSIGMA-FC FUSION PROTEIN AND PHARMACEUTICAL COMPOSITION COMPRISING SAME

Methods of activating cytotoxic leukocytes using PTP1B and PTPN2 inhibitors

SYSTEMS AND METHODS FOR ENHANCED IMMUNOTHERAPIES

Oligomeric Compounds Comprising Bicyclic Nucleotides and Uses Thereof

ANTI-TUMOR FUSION PROTEIN, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

LOOPED PROTEINS COMPRISING CELL PENETRATING PEPTIDES

HYPOXIA-RESISTANT NATURAL KILLER CELLS

REGULATION OF POST-ISCHEMIC INFLAMMATORY RESPONSE: A NOVEL FUNCTION OF TYROSINE PHOSPHATASE STEP

POLYNUCLEOTIDES FOR DISRUPTING IMMUNE CELL ACTIVITY AND METHODS OF USE THEREOF

PTPRS AND PROTEOGLYCANS IN AUTOIMMUNE DISEASE

CHIMERIC INHIBITORY RECEPTOR

ANTIGEN-SPECIFIC T CELL RECEPTORS AND T CELL EPITOPES

GENE KNOCK-OUTS TO IMPROVE T CELL FUNCTION

Neoantigen peptide mimics

CELL PENETRATING PEPTIDES AND METHODS OF MAKING AND USING THEREOF

COMPOSITIONS AND METHODS TO MANUFACTURE TUMOR SUPPRESSOR FUSIONS

TARGETED SENSITIZATION OF NON-DEL(5q) MALIGNANT CELLS

ONCOLYTIC VIRUSES TARGETING STAT3

ONCOLYTIC VIRUSES TARGETING STAT3

Recombinant Bacteria And Uses Thereof

High affinity SIRP-alpha reagents and methods of using

A COMPOSITION COMPRISING MESENCHYMAL STEM CELLS FOR INHIBITING ADIPOGENESIS

Methods and compositions for inducing neural plasticity

CO-DELIVERY OF NUCLEIC ACIDS FOR SIMULTANEOUS SUPPRESSION AND EXPRESSION OF TARGET GENES

DATA PROCESSING SYSTEM FOR IDENTIFYING A THERAPEUTIC AGENT

Non-human animals having a humanized signal-regulatory protein gene

CELL

CELL

YEAST OVER-EXPRESSING PROTEIN PHOSPHATASES ASSOCIATED WITH THE HOG PATHWAY

METHOD OF PRODUCING LEUKOCYTES USING PTPN2 INHIBITION FOR ADOPTIVE CELL TRANSFER

Methods and Materials for Producing Polyols and Electron Rich Compounds

Oligomeric compounds comprising bicyclic nucleotides and uses thereof

ROBUST PANELS OF COLORECTAL CANCER BIOMARKERS

Cell penetrating peptides and methods of making and using thereof

CHIMERIC TRANSMEMBRANE RECEPTORS AND USES THEREOF

Pharmaceutical composition for treating or preventing Parkinson's disease comprising STT as an active ingredient

MOLECULAR PROFILING FOR CANCER

SIRP-ALPHA VARIANT CONSTRUCTS AND USES THEREOF

Non-human animals having a humanized signal-regulatory protein gene

Compositions and methods for enhancing macrophage-mediated antibody guided cancer cell or tumor eradication

PROTEOGLYCAN IRREGULARITIES IN ABNORMAL FIBROBLASTS AND THERAPIES BASED THEREFROM

METHOD FOR THE EXTRACTION OF RECOMBINANT PROTEINS

CO-DELIVERY OF NUCLEIC ACIDS FOR SIMULTANEOUS SUPPRESSION AND EXPRESSION OF TARGET GENES

CRISPR-Cas9 Knock-out of SHP-1/2 to Reduce T cell Exhaustion in Adoptive Cell Therapy

Genetically modified non-human animals expressing human EPO

SHP INHIBITOR COMPOSITIONS AND USES FOR CHIMERIC ANTIGEN RECEPTOR THERAPY

CELL

Cell

Compositions and methods of treating root avulsion injury

Oligonucleotide compositions with enhanced efficiency

SIGNAL TRANSDUCTION MODIFYING PROTEIN

Method and system for treating cancer and other age-related diseases by extending the healthspan of a human

Methods and compositions for in vivo induction of pancreatic beta cell formation

STEP-derived peptide for brain injury treatment

Oncolytic viruses targeting STAT3

Co-activation of mTOR and STAT3 pathways to promote neuronal survival and regeneration

Non-human animals having a humanized signal-regulatory protein gene

Antigen-specific T cell receptors and T cell epitopes

Skin-penetrating peptide and method for using same

Cell

Oligonucleotide compositions with enhanced efficiency

DOUBLE-STRANDED OLIGONUCLEOTIDES

SIRP-ALPHA VARIANT CONSTRUCTS AND USES THEREOF

Targeted sensitization of non-del(5q) malignant cells

Methods and compositions for promoting thermogenic potential

Cell

Method for measuring tyrosine phosphatase and tyrosine kinase activity

Selective gene therapy expression system

Modulators of protein tyrosine phosphatase and uses thereof

CLATHRIN THERAPEUTIC FOR NEUROPSYCHIATRIC DISEASES & DISORDERS

CLATHRIN THERAPEUTIC FOR PSYCHIATRIC DISORDERS

Oligomeric compounds comprising bicyclic nucleotides and uses thereof

PROTEIN COATING COMPOSITION

High affinity SIRP-alpha reagents and methods of using

Non-human animals having a humanized signal-regulatory protein gene

Methods to Prepare and Employ Binding Site Models for Modulation of Phosphatase Activity and Selectivity Determination

NUCLEIC ACID CONSTRUCT FOR EXPRESSING MORE THAN ONE CHIMERIC ANTIGEN RECEPTOR

Nucleic acid construct

Oligonucleotide compositions with enhanced efficiency

MOLECULAR PROFILING FOR CANCER

Co-activation of mTOR and STAT3 pathways to promote neuronal survival and regeneration

Cell penetrating peptides and methods of making and using thereof

Method and system for treating cancer and other age-related diseases by extending the healthspan of a human

Oligonucleotide compositions with enhanced efficiency

Methods and compositions for in vivo induction of pancreatic beta cell formation

Non-human animals having a humanized signal-regulatory protein gene

CDC25A inhibitor for the treatment of drug resistant cancer or for the prevention of tumor relapse

Modulation of PTPRA to treat arthritis

DIAGNOSIS OF CANCER

METHOD OF PRODUCING LEUKOCYTES USING PTPN2 INHIBITION FOR ADOPTIVE CELL TRANSFER

Cell penetrating peptides and methods of making and using thereof

Method and system for treating cancer cachexia

Pharmaceutical composition for preventing or treating neurodegenerative diseases

Antigen-specific T cell receptors and T cell epitopes

Compositions and methods of treating root avulsion injury

COMPOSITION TO REPURPOSE DRUGS

Non-human animals having a humanized signal-regulatory protein gene

Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin

Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin

SIRP-ALPHA VARIANT CONSTRUCTS AND USES THEREOF

CELL

Composition comprising a cell sample from a subject with scoliosis and a reagent for detecting PTPμ or PIPK1y

Cell

Cell

Compositions and methods for prostate cancer analysis

Generation of lineage-restricted progenitor cells from differentiated cells

SIRP-ALPHA VARIANT CONSTRUCTS AND USES THEREOF

SIRP-α immunoglobulin fusion proteins

Autoimmune disease treatments

Selective gene therapy expression system

Non-human animals having a humanized signal-regulatory protein gene

Artificial synthetic cDNA and method for detecting secondary glioblastoma

Compositions and methods for inhibiting the activity of LAR family phosphatases

Methods and compositions for treating cancer

Targeted sensitization of non-del(5q) malignant cells

Genetically modified non-human animals expressing human EPO

Antisense modulation of PTP1B expression

Fragment ligated inhibitors selective for the polo box domain of PLK1

Protein Tyrosine Phosphatase Mutations in Cancers

STEP-derived peptide for brain injury treatment

Methods and compositions for in vivo induction of pancreatic beta cell formation

Oligomeric compounds comprising bicyclic nucleotides and uses thereof

PTPRS AND PROTEOGLYCANS IN AUTOIMMUNE DISEASE

Non-human animals having a humanized signal-regulatory protein gene

Non-human animals having a humanized signal-regulatory protein gene

High affinity Sirp-alpha reagents and methods of using

Method for imparting environmental stress resistance to plants

Double-stranded oligonucleotides

Co-activation of mTOR and STAT3 pathways to promote neuronal survival and regeneration

Antisense modulation of PTP1B expression

STEP-derived peptide for brain injury treatment

Method of treatment of breast cancers over-expressing the SHP2 signature genes

Oligonucleotide compositions with enhanced efficiency

Compounds and therapeutic applications related to inhibition of dendritic cell immunoreceptor (DCIR) activity and signaling events

Use of -long leader sequence for transmembrane delivery of molecules

COMPOSITIONS AND METHODS FOR PROSTATE CANCER ANALYSIS

Double-stranded oligonucleotides

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 11 (PTPN11) AND TUMOR INITIATING CELLS

Antisense modulation of PTP1B expression

Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin

Fragment ligated inhibitors selective for the polo box domain of PLK1

MUTANT PTP ALPHA GENE GROUP IN MALIGNANT TUMORS AND PRODUCTION METHOD

Compositions and Methods for Therapy and Diagnosis of Cancer

COMPOSITIONS AND METHODS FOR THE TREATMENT OF KRABBE AND OTHER NEURODEGENERATIVE DISEASES

DOUBLE-STRANDED OLIGONUCLEOTIDES

Protein tyrosine phosphatase mutations in cancers

Antisense modulation of PTP1B expression

Methods for Treating Autophagy-Related Disorders

Conjugates For Use In Hepatocyte Free Uptake Assays

Compositions and their uses directed to PTPRU

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

Oligonucleotide Compositions with Enhanced Efficiency

Dynamic bio-nanoparticle elements

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF PTP1B GENES

RNA interference mediated treatment of alzheimer's disease using short interfering nucleic acid (siNA)

DOUBLE-STRANDED OLIGONUCLEOTIDES

Protein tyrosine phosphatase inhibitors

RNA INTERFERENCE MEDIATED INHIBITION OF PROTEIN TYROSINE PHOSPHATASE-1B (PTP-1B) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

RNA Interference Mediated Inhibition of Protein Tyrosine Phosphatase-1B (PTP-1B) Gene Expression Using Short Interfering RNA

Compositions and methods for therapy and diagnosis of cancer

MODULATION OF LMW-PTPASE EXPRESSION

RNA interference mediated inhibition of hypoxia inducible factor 1 (HIF1) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of hepatitis C virus (HCV) gene expression using short interfering nucleic acid (siNA)

METHODS AND COMPOSITIONS FOR MODULATING FOXO1 ACTIVITY AND INSULIN SIGNALING

RNA interference mediated treatment of Alzheimer's disease using short interfering nucleic acid (siNA)

Methods and Compositions for Modulating Body Weight and for Treating Weight Disorders and Related Diseases

Antisense modulation of PTP1B expression

RNA interference mediated inhibition of Stearoyl-CoA desaturase (SCD) gene expression using short interfering nucelic acid (siNA)

RNA interference mediated inhibition of MYC and/or MYB gene expression using short interfering nucleic acid (siNA)

Products and methods for treating PTP lar diseases

Double-Stranded Oligonucleotides

Compositions and their uses directed to PTPRU

Oligonucleotide-containing pharmacological compositions and their use

RNA interference mediated inhibition of hypoxia inducible factor 1 (HIF1) gene expression using short interfering nucleic acid (siNA)

Oligonucleotide-containing pharmacological compositions and their use

Oligonucleotide-containing pharmacological compositions and their use

Positionally modified siRNA constructs

DSP-10 DUAL-SPECIFICITY PHOSPHATASE

EphA2, EphA4 and LMW-PTP and methods of treatment of hyperproliferative cell disorders

Protein tyrosine phosphatase mutations in cancers

Polycationic compositions for cellular delivery of polynucleotides

RNA interference mediated treatment of Alzheimer's disease using short interfering nucleic acid (siNA)

METHOD AND COMPOSITION FOR ENHANCING BONE FORMATION

RNA INTERFERENCE MEDIATED TREATMENT OF ALZHEIMER'S DISEASE USING SHORT INTERFERING NUCLEIC ACID (siNA)

Method for activating T cell protein tyrosine phosphatase for therapeutic applications

Rna interference mediated inhibition of xiap gene expression using short interfering nucleic acid (sina)

Rna interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (sina)

Coumarin-based amino acids for use in enzyme activity and substrate specificity assays

Isolated PTPMT1 protein which mediates insulin production and uses thereof

Crystalline phosphatase and method for use thereof

RNA interference mediated inhibition of cyclin dependent kinase-2 (CDK2) gene expression using short interfering nucleic acid (siNA)

Proteins involved in the regulation of energy homeostasis

RNA interference mediated inhibition of MAP kinase gene expression or expression of genes involved in MAP kinase pathway using short interfering nucleic acid (siNA)

Compositions and methods for the treatment of body weight disorders, including obesity

Transgenic mice containing NTTP1 phosphatase gene disruptions

Low molecular weight protein tyrosine phosphatase (LMW-PTP) as a diagnostic and therapeutic target

Conjugates for use in hepatocyte free uptake assays

Antisense modulation of PTP1B expression

RNA interference mediated inhibition of protein tyrosine phosphatase-1B (PTP-1B) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibtion of protein tyrosine phosphatase-1B (PTP-1B) gene expression using short interfering nucleic acid (siNA)

Human phosphatase RET31, and variants thereof

Double-stranded oligonucleotides

DSP-10 dual-specificity phosphatase

Antisense modulation of ptpn12 expression

Sequential delivery of oligomeric compounds

RNA interference mediated inhibition of stearoyl-CoA desaturase (SCD) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of matrix metalloproteinase 13 (MMP13) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of platelet derived growth factor (PDGF) and platelet derived growth factor receptor (PDGFR) gene expression using short interfering nucleic acid (siNA)

Polycationic compositions for cellular delivery of polynucleotides

Hepatocyte free uptake assays

Nucleic acid mediated inhibition of enterococcus infection and cytolysin toxin activity

RNA interference mediated treatment of Alzheimer's disease using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of vascular cell adhesion molecule (VCAM) gene expression using short interfering nucleic acid (siNA)

Antisense modulation of dual specific phosphatase 5 expression

RNA interference mediated inhibition of GRB2 associated binding protein (GAB2) gene expression using short interfering nucleic acis (siNA)

RNA interference mediated treatment of polyglutamine (polyQ) repeat expansion diseases using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of intercellular adhesion molecule (ICAM) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of NF-Kappa B / REL-A gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of GPRA and AAA1 gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of cholinergic muscarinic receptor (CHRM3) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of protein tyrosine phosphatase type IVA (PRL3) gene expression using short interfering nucleic acid (siNA)

Viral proteins capable of binding LAR

RNA interference mediated inhibition of B-cell CLL/Lymphoma-2 (BCL-2) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of epidermal growth factor receptor (EGFR) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of cholesteryl ester transfer protein (CEPT) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of 5-alpha reductase and androgen receptor gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of ADAM33 gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of platelet-derived endothelial cell growth factor (ECGF1) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of type 1 insulin-like growth factor receptor gene expression using short interfering nucleic acid (siNA)

Hepatocyte free uptake assays

RNA interference mediated inhibition of polycomb group protein EZH2 gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of chromosome translocation gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of angiopoietin gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of gastric inhibitory polypeptide (GIP) and gastric inhibitory polypeptide receptor (GIPR) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of Myc and/or Myb gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of proliferating cell nuclear antigen (PCNA) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of telomerase gene expression using short interfering nucleic acid (siNA)

EphA2, EphA4 and LMW-PTP and methods of treatment of hyperproliferative cell disorders

RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (SINA)

RNA interference mediated target discovery and target validation using short interfering nucleic acid (siNA)

Polynucleotides encoding the novel human phosphatase, RET31, and variants thereof

RNA interference mediated inhibition of wingless gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of CXCR4 gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of TRPM7 gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of myostatin gene expression using short interfering nucleic acid (siNA)

RNA mediated inhibition connexin gene expression using short interfering nucleic acid (siNA)

Antisense modulation of PTP1B expression

RNA interference mediated inhibition of Fos gene expression using short interfering nucleic acid (siNA)

DSP-5 dual-specificity phosphatase

RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)

Antisense modulation of ptpn2 expression

RNA interference mediated inhibtion of tyrosine phosphatase-1B (PTP-1B) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)

Use of double-stranded ribonucleic acid for inducing cell lysis

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (SiNA)

Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin

Ptp10d, tec protein tyrosine kinase and edtp homologous proteins involved in the regulation of energy homeostasis

PTP4A1 as a therapeutic target for fibrotic diseases and disorders including systemic sclerosis